Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-026735
Filing Date
2024-11-13
Accepted
2024-11-13 17:31:55
Documents
2
Period of Report
2024-11-11

Document Format Files

Seq Description Document Type Size
1 form3-11132024_101152.html 3  
1 form3-11132024_101152.xml 3 1673
2 ex24-11132024_101152.htm EX-24 4775
  Complete submission text file 0001415889-24-026735.txt   7895
Mailing Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142
Business Address
Tanguler Tolga (Reporting) CIK: 0001849458 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41855 | Film No.: 241455849

Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Issuer) CIK: 0001907108 (see all company filings)

EIN.: 854012572 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)